Margaret Henry

Secretary at Adaptimmune Ltd.

Margaret Henry

Margaret Henry

Secretary at Adaptimmune Ltd.

Biography

Currently, Margaret Henry holds the position of Secretary & Head-Public Relations at Adaptimmune Therapeutics Plc and Secretary of Adaptimmune Ltd. (a subsidiary of Adaptimmune Therapeutics Plc).

Overview
RelSci Relationships

24

Contact Data
Trying to get in touch with Margaret Henry? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Margaret Henry likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Business Officer at Adaptimmune Therapeutics PLC

Relationship likelihood: Strong

Former Partner at MediGene AG

Relationship likelihood: Strong

Co-Founder & CSO at Immunocore Ltd.

Relationship likelihood: Average

In-House Counsel at Adaptimmune Therapeutics PLC

Relationship likelihood: Average

Senior Director, Investor Relations at Adaptimmune Therapeutics PLC

Relationship likelihood: Average

Vice President-Quality Assurance at Adaptimmune Therapeutics PLC

Relationship likelihood: Average

Former Vice President & Head-Biometrics at Adaptimmune Therapeutics PLC

Relationship likelihood: Average

Executive Vice President, Science & Technology at Cabaletta Bio, Inc.

Relationship likelihood: Average

Senior Vice President, Clinical Development at Adaptimmune Therapeutics PLC

Relationship likelihood: Average

Vice President, Human Resources at Zynerba Pharmaceuticals, Inc.

Relationship likelihood: Average

Paths to Margaret Henry
Potential Connections via
Relationship Science
You
Margaret Henry
Secretary at Adaptimmune Ltd.
Career History
Corporate Secretary
Current

Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.

Secretary
Current

Adaptimmune Ltd. develops T cell therapies to treat cancer, human immunodeficiency virus, and infectious diseases. It utilizes the T cell to target and destroy cancerous and infected cells by using affinity T cell receptor proteins as a means of strengthening patient T cell responses. The company was founded by Bent K. Jakobsen, James Julian Noble and Helena Katrina Tayton-Martin in 2008 and is headquartered in Oxford, the United Kingdom.

Transactions
Details Hidden

Adaptimmune Ltd. raised money in a private placement transaction

Other Affiliations

Margaret Henry is affiliated with Adaptimmune Therapeutics PLC, Adaptimmune Ltd.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Margaret Henry. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Margaret Henry's profile does not indicate a business or promotional relationship of any kind between RelSci and Margaret Henry.